Last close As at 05/08/2026
AUD1.47
▲ 0.05 (3.53%)
Market capitalisation
AUD2,002m
Research: Metals & Mining
Following a rain-sodden H1, the second half of FY17 saw a remarkable turnaround in gold production at the Tomingley Gold Operation (TGO), and brought down unit costs markedly as a result. With similar production and cost guidance to FY17 targeted for FY18 at the TGO, key catalysts will be those linked to the development of the Dubbo Project (DP). Commentary from Alkane (ALK) that key product markets (eg certain rare earths, zircon/zirconium) are recovering from their multi-year lows signals a return of focus to the company’s flagship project.
Alkane Resources |
TGO shows it can, and Dubbo’s value re-emerges |
Q4 & FY17 operating results |
Metals & mining |
27 July 2017 |
Share price performance
Business description
Next events
Analysts
Alkane Resources is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||
Following a rain-sodden H1, the second half of FY17 saw a remarkable turnaround in gold production at the Tomingley Gold Operation (TGO), and brought down unit costs markedly as a result. With similar production and cost guidance to FY17 targeted for FY18 at the TGO, key catalysts will be those linked to the development of the Dubbo Project (DP). Commentary from Alkane (ALK) that key product markets (eg certain rare earths, zircon/zirconium) are recovering from their multi-year lows signals a return of focus to the company’s flagship project.
Year end |
Revenue (A$m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
06/15 |
101.8 |
0.1 |
1.0 |
0.0 |
35.0 |
N/A |
06/16 |
109.6 |
11.0 |
2.2 |
0.0 |
15.9 |
N/A |
06/17e |
117.8 |
17.8 |
2.2 |
0.0 |
15.9 |
N/A |
06/18e |
102.6 |
(38.7) |
(3.5) |
0.0 |
N/A |
N/A |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Record production, grade and lowest costs for Q4
Q4 gold production was 27,924oz at AISC costs of A$905/oz and C1 cash costs of A$702/oz. This was a quarter-on-quarter production increase of a high 49% and demonstrates not only the impact high rainfall had on operation during H117, but also the efficiency of Alkane’s mining teams at the TGO in getting ore out of the ground and into saleable gold ounces.
Certain of DP’s end-markets see daylight again
We have been monitoring rare-earth element (REE) prices via the Steelhome REE price portal on Bloomberg, and agree with Alkane’s statement that certain (predominantly relating to magnet production) REE prices are experiencing stronger demand and increased pricing as a result. Also important to the DP’s future viability due to the relatively large proportions mined is the rebound in zircon and zirconium-based product prices. Both, as well as the relatively stable niobium prices, lend significant weight to the DP being developed on a modular development basis (currently being finalised by industry experts Outotec).
Valuation: Up 16% on share price increase alone
We have incorporated TGO FY18 production guidance of 65-67koz (we assume 65koz), and base our valuation from FY18 and maintain our DP funding assumptions with first capex spend this financial year (FY18). Applying ALK’s higher prevailing share price (A$0.35, vs A$0.26 previously) for notional future funding has the automatic effect of increasing our valuation 16% to A$0.71/share for the TGO and DP combined (previously A$0.61). With all other pricing, project development and mine schedule assumptions unchanged, we see considerable scope for upside as DP catalysts emerge in the form of commercial offtake and financing. We also look to the company releasing updated TGO mine plans and DP modular design cost inputs, which we will use to revise our valuation.
Mining gets back on track, Dubbo’s fortunes return
Strong production performance of 17koz of gold produced across April and May led Alkane, at end June, to revise upwards its H217 production target from 31-36koz, to 43-45koz. H217 all-in sustaining costs (AISC) also came down to the range estimated by the Alkane in January 2017 of A$1,350-1,550/oz, to A$1,000-1,100/oz. This has had a marked positive effect on the company’s full year cash flow from operations, with A$32.7m realised (net of development costs), and its cash position has also grown to A$42.0m from A$24.4m in FY16.
Alkane’s strong H2 production performance at the TGO had also led the company to revise its full-year FY17 production guidance to 65-67koz Au at all-in sustaining costs of between A$1,300/oz and A$1,400/oz. This is 12% above our TGO gold production estimate for FY17 (published in May 2017) of 58koz, and slightly ahead of our AISC estimate for FY17 of A$1,469/oz.
This positive H217 production performance sees Alkane finishing FY17 with a flourish, after a difficult H117 dominated by intense periods of rainfall, which negatively affected gold mining at the TGO. Further, Alkane has guided that it expects to produce 65-70koz of gold in FY18 at an AISC of between A$1,100/oz to A$1,200/oz. We expect to revise our base case valuation for the TGO, and Alkane’s shares, pending its release of formal revised underground mine plans for the TGO, sometime towards the end of H118 (H2 of CY17). This will follow the completion of current drilling activities and a revised resource and reserve statement for the TGO.
|
Exhibit 1: Quarterly production data – Q417 sees record production and grade |
|
|
Source: Edison Investment Research, Alkane Resources |
Similar production to FY17 forecast for next year
As a direct result of improved mining conditions, operating costs reduced markedly across FY17, as detailed in Exhibit 2 below. Alkane guides to similar production and cost levels being achieved for the TGO during FY18 (notwithstanding any further disruptions due to high levels of rainfall like those experienced in H217). We therefore estimate 65koz of gold produced at an all-in sustaining cost of A$1,092/oz.
|
Exhibit 2: Quarterly unit cost breakdown |
||
C1 cash costs |
Additional costs to C1 |
With both costs levels |
|
|
|
|
Source: Edison Investment Research |
||
Exhibit 3: TGO quarterly production, stockpiles, costs and revenue breakdown
Production |
Unit |
Q117 |
Q217 |
Q317 |
Q417 |
FY17 |
Waste mined |
bcm |
1,533,279 |
1,799,904 |
2,165,717 |
2,180,210 |
7,679,110 |
Implied strip ratio |
tonnes |
18.3 |
15.4 |
23.0 |
13.1 |
16.6 |
Ore mined |
g/t |
221,139 |
318,216 |
249,109 |
434,404 |
1,222,868 |
Ore grade |
tonnes |
1.51 |
1.39 |
2.42 |
2.69 |
2.08 |
Ore milled |
g/t |
231,797 |
279,338 |
281,654 |
295,194 |
1,087,983 |
Head grade |
% |
1.50 |
1.48 |
2.36 |
3.10 |
2.15 |
Recovery |
ounces |
90.1% |
90.4% |
91.1 |
92.8% |
91.5% |
Gold recovered |
A$/oz |
10,435 |
11,756 |
18,721 |
27,924 |
68,836 |
Gold sold |
A$m |
10,000 |
12,519 |
16,303 |
31,107 |
69,929 |
Gold revenue |
A$/oz |
16.3 |
20.8 |
27.6 |
52.6 |
117.3 |
Implied realised gold price/ actual |
A$m |
1,627 |
1,694 |
1,694 |
1,690 |
1,678 |
Cost of sales |
A$/oz |
19.2 |
21.2 |
22.5 |
25.3 |
88.2 |
AISC operating cost |
% |
2,139 |
1,803 |
1,201 |
905 |
1,335 |
Gross Margin |
-11.6% |
6.1% |
58.3% |
140.7% |
48.9% |
|
|
||||||
|
||||||
Stockpiles and bullion on hand |
|
|||||
Ore for immediate milling |
tonnes |
3,368 |
2,572 |
4,986 |
1,814 |
1,814 |
Bullion on hand |
ounces |
5.48 |
4.36 |
8.20 |
2.98 |
30.5 |
Value of bullion on hand (based on implied gold price above) |
A$m |
661,645 |
709,148 |
620,271 |
761,829 |
761,829 |
|
||||||
Stockpile grade |
g/t Au |
0.80 |
0.79 |
0.75 |
0.95 |
0.95 |
Contained gold in stockpiles |
oz |
17,201 |
18,195 |
15,126 |
23,300 |
18,195 |
Value of stockpiled gold ounces at quarter's average price |
A$m |
28.0 |
30.8 |
25.6 |
39.4 |
30.5 |
|
||||||
Detailed cost summary |
|
|||||
Mining |
A$/oz |
1,188 |
1,029 |
721 |
485 |
748 |
Processing |
A$/oz |
505 |
450 |
269 |
168 |
295 |
Site support |
A$/oz |
148 |
118 |
80 |
49 |
84 |
C1 site cash costs |
A$/oz |
1,841 |
1,597 |
1,070 |
702 |
1,127 |
Royalties |
A$/oz |
35 |
40 |
51 |
57 |
49 |
Sustaining capital |
A$/oz |
130 |
37 |
8 |
46 |
47 |
Rehabilitation |
A$/oz |
68 |
72 |
38 |
71 |
71 |
Corporate |
A$/oz |
65 |
57 |
34 |
29 |
41 |
AISC |
A$/oz |
2,139 |
1,803 |
1,201 |
905 |
1,335 |
Source: Edison Investment Research
Dubbo’s end-markets rebound
A key concern to investors about Dubbo has been the state of its respective end-product markets. Since the 2011 rare earth bubble, rare earth metal prices have consistently dropped in value, not only as the commodity boom in China ended, but also as worldwide demand slowed in general. Matters were exacerbated by development of Lynas Corporation’s Mt Weld project in Western Australia and the relatively short lived re-opening of Molycorps’s Mountain Pass project. However, both the aforementioned projects were largely light rare earth dominant and created a situation of oversupply, namely within the lanthanum and cerium markets.
Fast forward to today, and specific rare earth and specialist metal markets are seemingly changing for the better (see price charts in Exhibit 6). The metals given in Exhibit 6 are experiencing price increases mainly as a result of the growth in renewable energy production, but also due to Chinese environmental auditing and closure of illegal mine sites. The main consumers and drivers for growth in rare earths and specialty metals demand relate to, among others, the manufacture of magnets used in (wind) turbine technologies and the uses of rare earths throughout the spectrum of renewable energy technologies and the associated electronic infrastructure required to support it. A stark indication of the average growth rates in solar photovoltaic and wind turbine energy supply across a 25-year time span, as calculated by the International Energy Agency, is given in the following exhibit.
|
Exhibit 4: Annual average annual growth rates of world renewables supply, 1990-2015 |
|
|
Source: International Energy Agency, Renewables Information: Overview (2017 edition) |
The above chart should be viewed in conjunction with the following exhibit, which details the percentage share of fuels used in energy production worldwide in 2015. While solar, wind, geothermal and tidal technologies only account for 1.5% of the fuel share in the world’s total primary energy supply, the growth rates given in the above exhibit clearly support demand for specific rare earth and specialty metals.
|
Exhibit 5: 2015 fuel shares in world total primary energy supply |
|
|
Source: International Energy Agency, Renewables Information: Overview (2017 edition) |
The following price charts are taken from Alkane’s quarterly report and detail key Chinese US dollar metal prices.
|
Exhibit 6: Key 2017 metal prices for a suite of Dubbo end-products |
|
|
Source: Argus Metals, Alkane Resources quarterly update report |
Vietnam Rare Earth JSC – Alkane’s downstream processor
The memorandum of understanding (MoU) signed with Vietnam Rare Earth JSC (VTRE) in April 2016 was originally valid for 12 months, but has been extended to allow Alkane to complete exhaustive due diligence on VTRE to make sure it can deliver the quality of product at forecast cost levels to end-users. After this due diligence period, Alkane will also have the option to purchase equity in VTRE (details of this potential purchase are not available). VTRE has been separating rare earth concentrates into separated rare earth metals since 2012 and, according to Alkane’s management, achieves this at cost levels similar to those of the rare earth processors in China. If true, it has a major competitive edge over Western rare earth developers looking to refine in house.
During Q417 Alkane signed a toll treatment agreement with VTRE as a further development to the aforementioned MoU. Toll treatment of Dubbo rare earth concentrates is favoured by Alkane as construction and operation of a dedicated rare earth separation plant at the Dubbo site is considered to add some complexity to the project.
Alkane has therefore been in the process of undertaking considerable due diligence at Vietnam Rare Earth’s processing facility. Key to this due diligence process has been the supply by Alkane of 80 tonnes of rare earth concentrate (bought on market by Alkane’s subsidiary, ASM) to VTRE, from which 31 tonnes of refined rare earth oxides have now been produced. We are unsure of the exact quantities of rare earths contained within the concentrate shipped, or whether it had similar characteristics to the concentrate that could be produced from Dubbo. However, Alkane does state that the concentrate contains cerium and lanthanum (which are in general oversupply and due to be stockpiled and not sold once Dubbo is in production) and praseodymium and neodymium (which will be produced and sold; they are key magnet metals and will be important revenue streams to Alkane).
Alkane states that final processing will be completed in July, after which Alkane will be able to validate VTRE’s processing technology as well as the quality of the refined metals and oxides produced, commercial logistics and sales capabilities.
Zirconium and lanthanum could improve Li-ion battery performance
We feel it is worth repeating Alkane’s observation that zirconium and lanthanum could improve Li-ion battery performance. It concerns research currently being undertaken by Michigan University into the use of solid electrolytes in lithium-ion batteries. The research involves the use of a film made of lithium-lanthanum-zirconate, using proportions of lithium hydroxide (20%), lanthanum oxide (53%) and zirconia (27%). The rise of the electric vehicle, either hybrid-electric or pure-electric, would greatly benefit from this battery technology being commercialised as it allows li-ion batteries to operate at higher temperatures as well as having a greater energy density. This would allow for batteries to be made lighter with a potential positive impact on vehicle range, a key anxiety of electric vehicle customers.
Status of DP product agreements and end-markets
A key risk of the DP is securing commercial offtake partner agreements for its different products. Securing such agreements is critical to Alkane’s ability to generate revenue from its suite of products that have no open market on which to be sold. The following table summarises the current agreements that Alkane has in place for its DP products.
Exhibit 7: Summary of DP product agreements
Product |
Status of product agreements |
Date agreement signed |
Expiry date |
Company |
Zirconium products |
MoU to market zirconium products in Europe and North America. |
15 August 2012 |
31 December 2014 |
European trading and manufacturing company – moving to agreement |
Refined REE output |
MoU with Vietnam Rare Earth JSC to toll process ASM’s rare earths concentrate into separated rare earth products. |
March 2016 |
2027 with option to extend |
Vietnam Rare Earth JSC |
Niobium concentrate |
Framework agreement whereby TIAG and ASM jointly process DP niobium into FeNb ready for subsequent sale. |
17 July 2013 |
N/A |
Treibacher Industrie AG |
Source: Alkane corporate announcements
With only one agreement in place with Treibacher Industrie (TIAG) over the DP’s future production, Alkane intends to finalise agreements on its zirconium and rare earth output over the remainder of CY17. It has marketed extensively through Europe and the US over the last few years and has been stepping up its efforts. Although TIAG and VTRE have allowed their names to be disclosed, this is not a standard practice and the company name supporting zirconium offtake may not be announced. Regardless, Alkane will need to notify the market of finalised commercial offtake agreements in the coming months, such that it can maintain its development timeline and progress to first production in 2019.
Edison’s projected group revenue split for DP products are shown in Exhibit 8 below.
|
Exhibit 8: Group revenue split for FY20e |
|
|
Source: Edison Investment Research, Alkane Resources |
The chart above correlates to the following amounts being produced once in steady state production in 2023 (under our assumptions):
■
16,374t of high-purity zirconia products;
■
6,664t of rare earth chemical concentrate;
■
1,967t of niobium in c 3,000t of ferro-niobium;
■
50t of hafnium as HfO2; and
■
approximately 65,000oz Au from the TGO.
We provide a summary of the DP’s product suite below.
Zirconium – commercial terms being finalised
The sale of zirconium-based products, in the form of zirconium chemicals and chemical zirconia, constitutes the largest revenue stream (31% at projected prices) at group level for Alkane. The zircon market in all its forms has remained flat during recent years and, with zircon used in its most widespread form in building construction applications, demand is closely linked to infrastructure spending, especially out of China. Alkane’s discussions with potential customers are ongoing for commercialisation of its zirconium-based sales agreements.
Niobium – Treibacher Industrie
Subject to the effects of the oligopoly in this market, niobium prices remain flat at US$30-35/kg. Commercialisation of Alkane’s framework agreement with TIAG is also being converted into a commercial offtake agreement.
Hafnium – output revisions mirror industry needs
The DP’s future hafnium output is based on Alkane’s discussions with potential customers, primarily in the aerospace and industrial gas turbine industries, and its current understanding for the potential scale of this market once the DP is in production. Hafnium production will be 25tpa from start-up through to 2025, at which point it rises to 100tpa, resulting in annual revenues of A$80m pa at projected prices. Alkane’s management has stated that hafnium output could increase beyond 100tpa as the world market for this metal grows and accepts the DZP as an established long-term stable producer. Refined hafnium metal currently trades at US$1,200/kg, and we forecast that US$1,100/kg will be realised during the DP’s ramp-up period from 2018-20, followed by a flat US$800/kg over the remainder of the mine’s life (2036 under our assumptions).
Financials
Alkane saw its cash pile rise a massive 72% from end FY16, from A$24.5m to A$42.0m. To this can be added a further A$2.9m in gold bullion on hand.
If we take out all our financing assumptions for the DP in FY18, we see the TGO generating A$102.6m in revenue and EBITDA of A$25.9m. We estimate TGO capex of A$12m for development of an underground operation (NB this may well change) and exploration expenditure of A$4m.
On the basis of the above gold production and other cost assumptions, we forecast that, based on TGO alone, Alkane would finish FY18 with cash of A$46.0m.
Exhibit 12: Financial summary
A$'000s |
2014 |
2015 |
2016 |
2017e |
2018e |
||
Year end 30 June |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
PROFIT & LOSS |
|||||||
Revenue |
|
|
35,474 |
101,813 |
109,624 |
117,792 |
102,595 |
Cost of Sales |
(25,692) |
(74,809) |
(76,236) |
(72,405) |
(71,443) |
||
Gross Profit |
9,782 |
27,004 |
33,388 |
45,387 |
31,152 |
||
EBITDA |
|
|
3,890 |
26,478 |
40,913 |
47,874 |
25,869 |
Operating Profit (before GW and except.) |
3,890 |
(79) |
10,984 |
14,874 |
(39,352) |
||
Intangible Amortisation |
0 |
0 |
0 |
0 |
0 |
||
Exceptionals/discontinued |
(4,798) |
(8,211) |
(4,375) |
(20,475) |
63,244 |
||
Other |
0 |
0 |
0 |
0 |
0 |
||
Operating Profit |
(908) |
(8,290) |
6,609 |
(5,601) |
23,891 |
||
Net Interest |
(471) |
153 |
54 |
2,956 |
628 |
||
Profit Before Tax (norm) |
|
|
3,419 |
74 |
11,038 |
17,830 |
(38,725) |
Profit Before Tax (FRS 3) |
|
|
(1,379) |
(8,137) |
6,663 |
(2,645) |
24,519 |
Tax |
(4,893) |
4,051 |
(1,968) |
3,064 |
0 |
||
Profit After Tax (norm) |
(1,372) |
4,125 |
9,070 |
17,953 |
(38,725) |
||
Profit After Tax (FRS 3) |
(6,272) |
(4,086) |
4,695 |
419 |
24,519 |
||
Average Number of Shares Outstanding (m) |
373.7 |
413.4 |
420.8 |
819.4 |
1,121.8 |
||
EPS - normalised (c) |
|
|
(0.4) |
1.0 |
2.2 |
2.2 |
(3.5) |
EPS - FRS 3 (c) |
|
|
(1.7) |
(1.0) |
1.1 |
0.1 |
2.2 |
Dividend per share (c) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Gross Margin (%) |
27.6 |
26.5 |
30.5 |
38.5 |
30.4 |
||
EBITDA Margin (%) |
N/A |
N/A |
N/A |
N/A |
N/A |
||
Operating Margin (before GW and except.) (%) |
N/A |
N/A |
N/A |
N/A |
N/A |
||
BALANCE SHEET |
|||||||
Fixed Assets |
|
|
160,174 |
162,624 |
182,691 |
169,783 |
752,998 |
Intangible Assets |
53,406 |
65,251 |
72,553 |
55,078 |
59,078 |
||
Tangible Assets |
100,032 |
89,787 |
102,941 |
107,508 |
686,723 |
||
Investments |
6,736 |
7,586 |
7,197 |
7,197 |
7,197 |
||
Current Assets |
|
|
40,811 |
28,342 |
38,569 |
56,935 |
13,006 |
Stocks |
15,391 |
11,505 |
12,394 |
13,038 |
11,330 |
||
Debtors |
4,906 |
1,988 |
1,720 |
1,929 |
1,676 |
||
Cash |
15,569 |
14,849 |
24,455 |
41,969 |
0 |
||
Other available for sale financial assets |
4,945 |
0 |
0 |
0 |
0 |
||
Current Liabilities |
|
|
(14,726) |
(11,251) |
(10,448) |
(15,986) |
(329,689) |
Creditors |
(13,755) |
(9,726) |
(8,745) |
(14,283) |
(5,872) |
||
Short term borrowings |
0 |
0 |
0 |
0 |
(322,114) |
||
Other |
(971) |
(1,525) |
(1,703) |
(1,703) |
(1,703) |
||
Long Term Liabilities |
|
|
(12,039) |
(9,265) |
(20,502) |
(20,502) |
(20,502) |
Long term borrowings |
0 |
0 |
0 |
0 |
0 |
||
Other long term liabilities |
(12,039) |
(9,265) |
(20,502) |
(20,502) |
(20,502) |
||
Net Assets |
|
|
174,220 |
170,450 |
190,310 |
190,230 |
415,813 |
CASH FLOW |
|||||||
Operating Cash Flow |
|
|
(3,508) |
28,454 |
37,432 |
51,416 |
19,419 |
Net Interest |
(369) |
153 |
54 |
15 |
628 |
||
Tax |
0 |
0 |
0 |
3,064 |
0 |
||
Capex |
(95,281) |
(32,588) |
(40,423) |
(40,567) |
(648,437) |
||
Acquisitions/disposals |
40,534 |
3,151 |
416 |
0 |
63,244 |
||
Financing |
9,800 |
162 |
12,127 |
3,585 |
201,064 |
||
Dividends |
0 |
0 |
0 |
0 |
0 |
||
Net Cash Flow |
(48,824) |
(668) |
9,606 |
17,514 |
(364,083) |
||
Opening net debt/(cash) |
|
|
(64,294) |
(15,569) |
(14,849) |
(24,455) |
(41,969) |
HP finance leases initiated |
0 |
0 |
0 |
0 |
0 |
||
Other |
99 |
(52) |
0 |
(0) |
0 |
||
Closing net debt/(cash) |
|
|
(15,569) |
(14,849) |
(24,455) |
(41,969) |
322,114 |
Source: Alkane Resources accounts, Edison Investment Research
|
|
Intec is moving closer to data from its clinical programmes to validate the utility of its unique drug delivery platform, the accordion pill (AP). The AP is specifically designed to improve gastroretention as a controlled release solution for difficult-to-formulate drugs. The lead programme is a Phase III study of AP-CDLD (carbidopa and levodopa) in Parkinson’s, which is expected to be completely enrolled in Q417. It is also in a Phase I clinical study (targeting Q317 completion) of AP-CDB/THC (cannabidiol and tetrahydrocannabinol) for the treatment of pain and is seeking a development partner for is sleep aid, AP-ZP (zaleplon).